Is clinical trial data showing positive progress for the treatment of diabetic kidney disease?

被引：1
|
作者：
Tan, Seng Kiong [1 ,2 ]
Cooper, Mark E. [1 ]
机构：
[1] Monash Univ, Cent Clin Sch, Dept Diabet, Level 5,99 Commercial Rd Melbourne, Melbourne, Vic 3004, Australia
[2] Khoo Teck Puat Hosp, Diabet Ctr, 90 Yishun Cent, Singapore 768828, Singapore
来源：
EXPERT OPINION ON EMERGING DRUGS | 2023年 / 28卷 / 04期
关键词：
Diabetic kidney disease; diabetic nephropathy; diabetes mellitus; renoprotection; diabetic complications; therapeutics; INTENSIVE GLUCOSE CONTROL; CARDIOVASCULAR OUTCOMES; ORAL SEMAGLUTIDE; FOLLOW-UP; TYPE-2; COMPLICATIONS; ALBUMINURIA; FINERENONE; INHIBITORS; SAFETY;
D O I：
10.1080/14728214.2023.2277762
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：217 / 226
页数：10
相关论文
共 50 条
  • [21] Continuous Positive Airway Pressure Effect on Albuminuria Progression in Patients with Obstructive Sleep Apnea and Diabetic Kidney Disease A Randomized Clinical Trial
    Zamarron, Ester
    Jaureguizar, Ana
    Garcia-Sanchez, Aldara
    Diaz-Cambriles, Trinidad
    Alonso-Fernandez, Alberto
    Lores, Vanesa
    Mediano, Olga
    Troncoso-Acevedo, Fernanda
    Cabello-Pelegrin, Sheila
    Morales-Ruiz, Enrique
    Ramirez-Prieto, Maria T.
    Isabel Valiente-Diaz, Maria
    Gomez-Garcia, Teresa
    Casitas, Raquel
    Martinez-Ceron, Elisabet
    Galera, Raul
    Cubillos-Zapata, Carolina
    Garcia-Rio, Francisco
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (06) : 757 - 767
  • [22] Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives
    Shaikh, Aisha
    Ray, Justina
    Campbell, Kirk N.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 753 - 760
  • [23] Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
    Kruger, Davida
    Valentine, Virginia
    [J]. DIABETES THERAPY, 2020, 11 (06) : 1237 - 1250
  • [24] Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
    Davida Kruger
    Virginia Valentine
    [J]. Diabetes Therapy, 2020, 11 : 1237 - 1250
  • [25] Research Progress on Application of Inonotus obliquus in Diabetic Kidney Disease
    Wang, Shuyue
    Wang, Ruihua
    Li, Rongshan
    Li, Yafeng
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 6349 - 6359
  • [26] Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney Disease
    Cherney, David Z.
    Tuttle, Katherine R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (04): : 444 - 446
  • [27] Treatment of Diabetic Kidney Disease: Current and Future
    Yamazaki, Tomotaka
    Mimura, Imari
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    [J]. DIABETES & METABOLISM JOURNAL, 2021, 45 (01) : 11 - 26
  • [28] Present and Future in the Treatment of Diabetic Kidney Disease
    Quiroga, Borja
    Arroyo, David
    de Arriba, Gabriel
    [J]. JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [29] Renin inhibition in the treatment of diabetic kidney disease
    Komers, Radko
    [J]. CLINICAL SCIENCE, 2013, 124 (9-10) : 553 - 566
  • [30] JAK inhibition in the treatment of diabetic kidney disease
    Frank C. Brosius
    Katherine R. Tuttle
    Matthias Kretzler
    [J]. Diabetologia, 2016, 59 : 1624 - 1627
12345